P G Steinherz
Overview
Explore the profile of P G Steinherz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heerema N, Nachman J, Sather H, La M, Hutchinson R, Lange B, et al.
Leukemia
. 2004 Mar;
18(5):939-47.
PMID: 14999294
Monosomy 7 or deletions of 7q are associated with many myeloid disorders; however, the significance of such abnormalities in childhood acute lymphoblastic leukemia (ALL) is unknown. Among 1880 children with...
2.
Kolb E, Steinherz P
Leukemia
. 2003 Sep;
17(10):1967-72.
PMID: 14513046
We report the results of a phase 2 nonrandomized single-arm trial of a combination therapy for relapsed or refractory leukemia. From January 1999 to June 2002, 28 patients with multiple...
3.
Steinherz P, Seibel N, Ames M, Avramis V, Krailo M, Reid J, et al.
Leuk Lymphoma
. 2002 Dec;
43(10):1945-50.
PMID: 12481889
To determine the maximum tolerated dose (MTD) and assess the toxicity profile and pharmacokinetics of weekly gemcitabine infusions in pediatric patients with refractory hematologic malignancies. Fourteen patients under 21 years...
4.
Sposto R, Meadows A, Chilcote R, Steinherz P, Kjeldsberg C, Kadin M, et al.
Med Pediatr Oncol
. 2001 Dec;
37(5):432-41.
PMID: 11745871
Background: Early Children's Cancer Group (CCG) trials indicated that the cyclophosphamide, vincristine, methotrexate, and prednisone (COMP) regimen was superior to the LSA2L2 regimen for non-lymphoblastic (NLB) non-Hodgkin lymphoma (NHL). Studies...
5.
Gaynon P, Bostrom B, Hutchinson R, Lange B, Nachman J, Steinherz P, et al.
J Clin Oncol
. 2001 Apr;
19(7):1916-25.
PMID: 11283123
Purpose: We used duration of hospitalization as a surrogate for cost and event-free survival as a measure of effectiveness to estimate the cost-effectiveness ratios of various treatment regimens on Children's...
6.
Heerema N, Sather H, Sensel M, Lee M, Hutchinson R, Nachman J, et al.
J Clin Oncol
. 2000 Nov;
18(22):3837-44.
PMID: 11078497
Purpose: Little is known about nonrandom deletions of chromosome bands 13q12 to 13q14 (13q12-14) in acute lymphoblastic leukemia (ALL). We determined the prognostic significance of cytogenetically identified breakpoints in 13q12-14...
7.
Heerema N, Sather H, Sensel M, Zhang T, Hutchinson R, Nachman J, et al.
J Clin Oncol
. 2000 Apr;
18(9):1876-87.
PMID: 10784628
Purpose: Children with acute lymphoblastic leukemia (ALL) and high hyperdiploidy (> 50 chromosomes) have improved outcome compared with other ALL patients. We sought to identify cytogenetic features that would predict...
8.
Heerema N, Sather H, Sensel M, Lee M, Hutchinson R, Lange B, et al.
Leuk Lymphoma
. 2000 Apr;
36(5-6):467-78.
PMID: 10784391
We have compared outcome for 167 (9.0%) children with a del(6q) and 1713 (91%) children without a del(6q) treated on Children's Cancer Group (CCG) risk-adjusted treatment protocols for acute lymphoblastic...
9.
Heerema N, Sather H, Sensel M, Lee M, Hutchinson R, Nachman J, et al.
Cancer
. 2000 Apr;
88(8):1945-54.
PMID: 10760773
Background: The authors have determined the prognostic significance of cytogenetically detectable 12p abnormalities, which are frequent in children with acute lymphoblastic leukemia (ALL), in a large cohort of patients treated...
10.
Wolden S, Steinherz P, Kraus D, Zelefsky M, Pfister D, WOLLNER N
Int J Radiat Oncol Biol Phys
. 2000 Mar;
46(4):859-64.
PMID: 10705006
Purpose: Nasopharynx cancer is a rare malignancy in childhood. This study aims to determine the role of chemotherapy, the optimal dose of radiation, and the long-term outcome for children with...